NCT06923228: An ongoing trial by CAGE Bio Inc.
This trial is ongoing. It must report results 7 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06923228 |
|---|---|
| Title | A Single-Blind, Prospective Clinical Study to Assess the Efficacy, Safety and Tolerability of CGB-500 1% Tofacitinib Ointment vs. an Active Comparator for Atopic Dermatitis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 21, 2025 |
| Completion date | July 30, 2025 |
| Required reporting date | July 30, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |